Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05545930 · ClinicalTrials.gov registry record · NA

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)

A NA study of Blood Recovery, sponsored by University Hospitals Cleveland Medical Center.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05545930 is a NA study of Blood Recovery that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05545930, a NA study of Blood Recovery, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to compare two methods of recovering blood from surgical sponges used during heart and lung surgeries. The two methods are: 1) manually wringing sponges by hand, and 2) automated wringing sponges by an FDA approved suction device. Both methods are already in use in heart and lung surgeries at University Hospitals at the discretion of the surgeon.

Conditions Studied

Interventions

  • PROCEDURE Hand Wrung
  • DEVICE ProCell Wrung

Study Locations (1)

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-09-20
Est. Completion 2026-07-01
Phase NA

What the Registry Record Tells You About NCT05545930

The ClinicalTrials.gov registry entry for NCT05545930 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Recovery appearing as the primary indexed condition, and to 2 interventions - of which Hand Wrung is the first listed.

NCT05545930 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05545930 about?

NCT05545930 is a clinical study titled "Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)". The purpose of this research study is to compare two methods of recovering blood from surgical sponges used during heart and lung surgeries. The two methods are: 1) manually wringing sponges by hand, and 2) automated wringing sponges by an FDA approved suction device. Both methods are already in use...

What is the current status of trial NCT05545930?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-09-20. Estimated completion is 2026-07-01.

What conditions does trial NCT05545930 study?

This clinical trial studies the following conditions: Blood Recovery.

What interventions are being tested in trial NCT05545930?

The interventions under investigation include: Hand Wrung (PROCEDURE), ProCell Wrung (DEVICE).

Who is sponsoring clinical trial NCT05545930?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05545930 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.